This content is machine translated Current evidence, risk classes and new counseling options Hormonal contraception and cardiovascular risk Over 247 million women worldwide use hormonal contraception – the majority with combined oral contraceptives (COCs). This prevalence is accompanied by an ongoing medical responsibility: venous thromboembolism, ischemic strokes and...…
View Post 13 min This content is machine translated MACE risk, heart failure incidence and all-cause mortality Metabolic syndrome as a cardiovascular risk factor Current data from 2025/2026 show: 1.54 billion adults worldwide are affected – and the risk of serious cardiovascular events increases in proportion to the number of components. New evidence on...…
View Post 11 min This content is machine translated Type 2 diabetes: cardiovascular risk reduction is realistic Modern active ingredients and lifestyle – every step counts Although diabetics have an increased risk of developing cardiovascular diseases such as myocardial infarction, heart failure or stroke, scientific data suggests that protective effects can be achieved through the best...…
View Post 6 min This content is machine translated Hypertrophic cardiomyopathies (HCM) How do myosin inhibitors perform in different HCM phenotypes? Cardiac myosin inhibitors have been developed as a targeted therapeutic option for modulating sarcomere function. While in clinical trials in obstructive hypertrophic cardiomyopathy they brought about a greater improvement in...…
View Post 9 min This content is machine translated Cardiology Minimally invasive – the quiet triumph of modern heart surgery The median sternotomy was the standard approach for cardiac surgery for many decades. With the advent of minimally invasive procedures, the guiding question of cardiac surgery shifted: away from maximum...… CME-Test
View Post 10 min This content is machine translated Patients with leg swelling DVT and other common DDs with peripheral edema Swelling of the lower extremities is common, especially in older adults. Due to the complex interrelationships, the clarification of such findings in general practice is a challenge. The differential diagnostic...…
View Post 8 min This content is machine translated Obesity treatment: new study data Incretin mimetics for comorbidities such as type 2 diabetes, ASCVD, HF, OSAS Lifestyle-related measures are the basic framework in the treatment of overweight and obesity. However, in order to achieve and maintain the target weight, accompanying pharmacological or surgical measures are usually...…
View Post 5 min This content is machine translated Atrial fibrillation Anticoagulation after catheter ablation – for how long? In selected groups of patients with atrial fibrillation, ablation can lead to an improvement in symptoms and/or prognosis. To avoid complications, anticoagulation before, during and after ablation should be criteria-driven....…
View Post 6 min This content is machine translated Treatment of type 2 diabetes: paradigm shift continues Cardiorenal organ protection is increasingly coming to the fore Nowadays, the improvement of the cardiorenal prognosis in patients with type 2 diabetes is largely independent of the current metabolic situation. The focus of patient-oriented treatment is on quality of...…
View Post 4 min This content is machine translated Semaglutide and tirzepatide in HFpEF and T2D/obesity Prospect of improved cardiovascular prognosis Patients suffering from heart failure with preserved ejection fraction (HFpEF) are very often also affected by cardiometabolic comorbidities such as obesity and type 2 diabetes. Although previous randomized trials suggest...…
View Post 9 min This content is machine translated Omega-3 fatty acids for obesity and type 2 diabetes More fish oil for better lipid and HbA1c levels Omega-3 fatty acids have an anti-inflammatory and adipogenic effect in adipose tissue. They offer systemic benefits in metabolic and chronic inflammatory diseases. By modulating inflammation and improving insulin sensitivity, they...…
